CMRX News
Archived Headlines
- US IPO Recap: 9 set terms, 8 file as market springs to life 04/08/13
- Four IPOs set terms as April's US IPO calendar quickly builds 04/01/13
- Biotech company Chimerix sets terms for $85 million IPO 04/01/13
- US IPO Weekly Recap: Artisan Partners delivers best IPO pop from a US asset manager in years 03/10/13
- Biopharmaceutical company Chimerix files for a $85 million IPO 03/08/13
US IPO Recap: Six deals price in another strong week for filings
Led by two large deals from Puerto Rican transaction processor EVERTEC (EVTC) and homebuilder Taylor Morrison (TMHC), six US IPOs raised a total of more than $1.5 billion last...read more
Chimerix stock soars as two biotechs debut Thursday
Two biotechs, Chimerix (CMRX) and Omthera Pharmaceuticals (OMTH), debuted on Thursday, bringing the total to five deals that have priced in April. Chimerix finished the day up 34.2% and Omthera traded down 7.1%. The companies joined...read more
Chimerix prices upsized IPO at $14 midpoint
Chimerix, which is developing a potent antiviral drug for use in stem cell transplants, raised $102 million by offering 7.3 million shares at $14, within the range of $13 to $15. The company had originally planned to sell 6.1 million shares before upsizing the...read more
7 US IPOs planned for the week of Apr 8
The following IPOs are expected to price this week: Chimerix (CMRX), which is developing a potent antiviral drug for use in stem cell transplants, plans to raise $85...read more